Phase
Condition
Musculoskeletal Diseases
Joint Injuries
Arthritis And Arthritic Pain
Treatment
Placebo
Fexofenadine
Clinical Study ID
Ages 18-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
Moderate to severe RA (disease activity score-28 joints: DAS-28 > 3.2) wererecruited.
Age between 18 - 60 years having active disease according to the diagnosis of anexperienced rheumatologist, being under treatment with disease-modifyinganti-rheumatic drugs (DMARDs), not receiving cytokine inhibitors
Signing informed consent and willingness of the participant to accept randomizationto any assigned treatment arm.
Exclusion
Exclusion Criteria:
History of biological DMARDS.
History/presence of acute heart disease, liver and kidney diseases, COPD
Intolerance or allergy to fexofenadine or methotrexate
Alcohol abuse
Any changes in using medication (changing the dosage or type of medicines
Receive hormone replacement therapy, warfarin, and other anticoagulants
Study Design
Connect with a study center
Beni-Suef Hospital
Banī Suwayf,
EgyptActive - Recruiting
Faculty of Medicine - Beni Suef Hospital
Banī Suwayf,
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.